{
    "clinical_study": {
        "@rank": "159734", 
        "arm_group": [
            {
                "arm_group_label": "uncovered double bare metallic stent (S&G Biotech.)", 
                "arm_group_type": "Active Comparator", 
                "description": "uncovered double bare metallic stent"
            }, 
            {
                "arm_group_label": "uncovered single bare metallic stent (S&G Biotech.)", 
                "arm_group_type": "Active Comparator", 
                "description": "uncovered single bare metallic stent"
            }, 
            {
                "arm_group_label": "uncovered single bare metallic stent (Taewoong Medical.)", 
                "arm_group_type": "Active Comparator", 
                "description": "uncovered single bare metallic stent"
            }
        ], 
        "brief_summary": {
            "textblock": "Our study is the prospective randomized study for efficacy of uncovered double bare metallic\n      stent compared to uncovered single bare metallic stent in malignant biliary obstruction"
        }, 
        "brief_title": "A Prospective Randomized Study for Efficacy of Uncovered Double Bare Metallic Stent Compared to Uncovered Single Bare Metallic Stent in Malignant Biliary Obstruction", 
        "completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Malignant Biliary Obstruction", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  The patients who had malignant biliary obstruction\n\n        Exclusion Criteria:\n\n          -  The patients who had resectable biliary malignancy\n\n          -  The patients who had hilar obstruction\n\n          -  The patients who had duodenal obstruction\n\n          -  The patients who had other malignancy which is not related to biliary obstruction\n\n          -  The patients who had uncontrolled infection\n\n          -  The patients who had poor performance (ECOG =3 or 4)\n\n          -  The patients who were not acquired informed consent\n\n          -  The patients who had technically difficult structure for ERCP"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "72", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 29, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01869894", 
            "org_study_id": "4-2013-0204"
        }, 
        "intervention": [
            {
                "arm_group_label": "uncovered double bare metallic stent (S&G Biotech.)", 
                "description": "The patients who had malignant biliary obstruction will be enrolled our study. Enrolled patient will be randomized to three group (uncovered double bare metallic stent (S&G Biotech.) vs. uncovered single bare metallic stent (S&G Biotech.) vs. uncovered single bare metallic stent (Taewoong Medical.)). After metallic biliary stent insertion, enrolled patients will be followed at least one time per one month. Blood test (including total bilirubin, gamma-GT) will be done for follow-up study. During follow-up period, if biliary obstruction is suspected, imaging study (CT or MRCP) will be done. With such follow-up tools, we compare 6-month patency rate and median patency duration among three groups.", 
                "intervention_name": "metallic biliary stent insertion (double bare - S&G Biotech.)", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "uncovered single bare metallic stent (S&G Biotech.)", 
                "description": "The patients who had malignant biliary obstruction will be enrolled our study. Enrolled patient will be randomized to three group (uncovered double bare metallic stent (S&G Biotech.) vs. uncovered single bare metallic stent (S&G Biotech.) vs. uncovered single bare metallic stent (Taewoong Medical.)). After metallic biliary stent insertion, enrolled patients will be followed at least one time per one month. Blood test (including total bilirubin, gamma-GT) will be done for follow-up study. During follow-up period, if biliary obstruction is suspected, imaging study (CT or MRCP) will be done. With such follow-up tools, we compare 6-month patency rate and median patency duration among three groups.", 
                "intervention_name": "metallic biliary stent insertion (single bare - S&G Biotech.)", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "uncovered single bare metallic stent (Taewoong Medical.)", 
                "description": "The patients who had malignant biliary obstruction will be enrolled our study. Enrolled patient will be randomized to three group (uncovered double bare metallic stent (S&G Biotech.) vs. uncovered single bare metallic stent (S&G Biotech.) vs. uncovered single bare metallic stent (Taewoong Medical.)). After metallic biliary stent insertion, enrolled patients will be followed at least one time per one month. Blood test (including total bilirubin, gamma-GT) will be done for follow-up study. During follow-up period, if biliary obstruction is suspected, imaging study (CT or MRCP) will be done. With such follow-up tools, we compare 6-month patency rate and median patency duration among three groups.", 
                "intervention_name": "metallic biliary stent insertion (single bare - Taewoong Medical.)", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Malignant biliary obstruction", 
            "metal stent", 
            "patency"
        ], 
        "lastchanged_date": "August 6, 2013", 
        "location": {
            "contact": {
                "email": "mjchung@yuhs.ac", 
                "last_name": "Moon Jae Chung, MD", 
                "phone": "(82)2-2228-1978"
            }, 
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of", 
                    "zip": "120-752"
                }, 
                "name": "Severance Hospital, Yonsei University Health System"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "3", 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Korea: Institutional Review Board"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Primary end point : A. Median patency duration", 
            "measure": "Median patency duration", 
            "safety_issue": "No", 
            "time_frame": "Approximately 6 months later since the date of stent insertion"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01869894"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "results_reference": [
            {
                "PMID": "15082593", 
                "citation": "Isayama H, Komatsu Y, Tsujino T, Sasahira N, Hirano K, Toda N, Nakai Y, Yamamoto N, Tada M, Yoshida H, Shiratori Y, Kawabe T, Omata M. A prospective randomised study of \"covered\" versus \"uncovered\" diamond stents for the management of distal malignant biliary obstruction. Gut. 2004 May;53(5):729-34."
            }, 
            {
                "PMID": "1281903", 
                "citation": "Davids PH, Groen AK, Rauws EA, Tytgat GN, Huibregtse K. Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction. Lancet. 1992 Dec 19-26;340(8834-8835):1488-92."
            }
        ], 
        "secondary_outcome": {
            "description": "Secondary end point : A. 6-months patency rate", 
            "measure": "6-months patency rate", 
            "safety_issue": "No", 
            "time_frame": "Approximately 6 months later since the date of stent insertion"
        }, 
        "source": "Yonsei University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Yonsei University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "August 2013"
    }
}